These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26135934)

  • 1. Investigation of Renal Cell Carcinoma by Contrast-Enhanced Ultrasound- Predictive Value of Time Intensity Curve Analysis in Establishing Local Tumor Invasion and Stage: A Pilot Study.
    Tamas-Szora A; Socaciu M; Crișan N; Dobrotă F; Prunduș P; Bungărdean C; Buruian M; Coman I; Opincariu I; Badea R
    Urol J; 2015 Jul; 12(3):2173-81. PubMed ID: 26135934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
    Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
    Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric imaging of clear cell and papillary renal cell carcinoma using contrast-enhanced ultrasound (CEUS).
    Rübenthaler J; Reimann R; Hristova P; Staehler M; Reiser M; Clevert DA
    Clin Hemorheol Microcirc; 2015 Oct; 63(2):89-97. PubMed ID: 26484712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.
    Lu Q; Huang BJ; Xue LY; Fan PL; Wang WP
    AJR Am J Roentgenol; 2015 Sep; 205(3):W335-42. PubMed ID: 26295670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of histological subtypes of clear cell renal cell carcinoma using contrast-enhanced ultrasound (CEUS).
    Reimann R; Rübenthaler J; Hristova P; Staehler M; Reiser M; Clevert DA
    Clin Hemorheol Microcirc; 2015 Oct; 63(1):77-87. PubMed ID: 26484711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of contrast-enhanced ultrasound for differentiation of renal cell carcinoma subtypes and angiomyolipoma.
    Li CX; Lu Q; Huang BJ; Xue LY; Yan LX; Zheng FY; Wen JX; Wang WP
    Eur J Radiol; 2016 Apr; 85(4):795-802. PubMed ID: 26971426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma.
    Li QY; Li N; Huang QB; Luo YK; Wang BJ; Guo AT; Ma X; Zhang X; Tang J
    Cancer Imaging; 2019 Dec; 19(1):79. PubMed ID: 31791422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound using a time-intensity curve for the diagnosis of renal cell carcinoma.
    Aoki S; Hattori R; Yamamoto T; Funahashi Y; Matsukawa Y; Gotoh M; Yamada Y; Honda N
    BJU Int; 2011 Aug; 108(3):349-54. PubMed ID: 21044245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses.
    Dai C; Cao Y; Jia Y; Ding Y; Sheng R; Zeng M; Zhou J
    Abdom Radiol (NY); 2018 Mar; 43(3):672-678. PubMed ID: 28721478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The independent indicators for differentiating renal cell carcinoma from renal angiomyolipoma by contrast-enhanced ultrasound.
    Cao H; Fang L; Chen L; Zhan J; Diao X; Liu Y; Lu C; Zhang Z; Chen Y
    BMC Med Imaging; 2020 Mar; 20(1):32. PubMed ID: 32228606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology.
    Wang K; Guo B; Yao Z; Li G
    World J Surg Oncol; 2024 Jun; 22(1):145. PubMed ID: 38822338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound.
    Zhang W; Wang J; Chen L; Shi J
    BMC Urol; 2024 Jun; 24(1):129. PubMed ID: 38886684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.
    Xue LY; Lu Q; Huang BJ; Li Z; Li CX; Wen JX; Wang WP
    Eur J Radiol; 2015 Oct; 84(10):1849-56. PubMed ID: 26149528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma.
    Dong XQ; Shen Y; Xu LW; Xu CM; Bi W; Wang XM
    Chin Med J (Engl); 2009 May; 122(10):1179-83. PubMed ID: 19493467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
    Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
    Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot trial to evaluate the clinical usefulness of contrast-enhanced ultrasound in predicting renal outcomes in patients with acute kidney injury.
    Yoon HE; Kim DW; Kim D; Kim Y; Shin SJ; Shin YR
    PLoS One; 2020; 15(6):e0235130. PubMed ID: 32579595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound.
    Kasoji SK; Chang EH; Mullin LB; Chong WK; Rathmell WK; Dayton PA
    Ultrason Imaging; 2017 Mar; 39(2):126-136. PubMed ID: 27659687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
    Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
    Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.